Literature DB >> 4401564

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

C R Cleaveland, D G Shand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401564     DOI: 10.1002/cpt1972132181

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  28 in total

1.  Some aspects of the pharmacology of beta-adrenorecptor blockers.

Authors:  B Ablad; E Carlsson; C Dahlŏf; L Ek
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.

Authors:  G E Marlin; C R Kumana; C M Kaye; D M Smith; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 3.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 4.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

5.  Acebutolol in hypertension: relationships between drug concentration and effects.

Authors:  M A Martin; F C Phillips; G T Tucker; A J Smith
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

6.  Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.

Authors:  H Halkin; I Vered; A Saginer; B Rabinowitz
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

Review 7.  The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 8.  Oxidation phenotype and the metabolism and action of beta-blockers.

Authors:  M S Lennard
Journal:  Klin Wochenschr       Date:  1985-04-01

9.  Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.

Authors:  L Wong; R L Nation; W L Chiou; P K Mehta
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

10.  Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls.

Authors:  F M Gengo; S C Fagan; G Krol; H Bernhard
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.